“Raised AFP”的搜索结果，显示 161-170 项，共有 691 项

1. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal ...

2. 外科 - 临床试验- 妙佑医疗国际

   ... high risk of these complications in order to take preventive measures. A Study to Establish a Living Breast Organoid Biobank for Translational Research.

3. 外科 - 临床试验- 妙佑医疗国际

   ... high even if surgery is done as soon as possible. Traditionally, when the ascending aorta gets above 5.5 cm, surgery is recommended to replace the aorta ...

4. DIEP flap surgery - 妙佑医疗国际

   No reconstruction can completely replace a natural breast. But many people who have DIEP flap surgery report high long-term satisfaction with the appearance of ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

7. 外科 - 临床试验- 妙佑医疗国际

   ... high even if surgery is done as soon as possible. Traditionally, when the ascending aorta gets above 5.5 cm, surgery is recommended to replace the aorta ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...